StockData

Alto Ingredients vs Green Plains

ALTO and GPRE side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALTO and GPRE compare

Green Plains is the larger company, worth 3.2 times as much as Alto Ingredients ($880M against $279M).

On earnings, Green Plains is cheaper: it trades at 5.1× trailing earnings, against 5.5× for Alto Ingredients.

Alto Ingredients grew revenue faster over the last twelve months (1.1% versus −19.1% for Green Plains).

Green Plains keeps more of each dollar of sales as profit, with a net margin of 10.9% compared with 5.5% at Alto Ingredients.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALTOGPRE
Size and price
Market cap$279M$880M
Share price$3.60$12.56
Change, 1 year76.5%29.6%
Change, 5 years−28.7%−67.1%
Beta (5Y)−1.10−0.60
Employees390642
StockData Score
Total score1313
Valuation score45 (better)
Growth score2 (better)1
Performance score34 (better)
Health score4 (better)3
Dividend score00
Valuation
P/E5.5×5.1× (better)
P/S0.3× (better)0.5×
P/B1.1×0.9× (better)
EV/EBITDA5.2×4.6× (better)
P/FCF5.6× (better)11.0×
FCF yield17.9% (better)9.1%
Fair value$13.84$64.31
Margin of safety74.0%80.5% (better)
Growth
Revenue growth (TTM)1.1% (better)−19.1%
Revenue growth, 5Y average0.46%1.7% (better)
Profitability
Gross margin6.8%19.7% (better)
Operating margin3.8%9.3% (better)
Net margin5.5%10.9% (better)
FCF margin5.3% (better)4.4%
Return on equity22.2%22.9% (better)
Return on invested capital9.5%15.4% (better)
Financial health
Debt / equity0.23 (better)0.50
Net debt / EBITDA0.60 (better)1.21
Interest coverage3.8×5.0× (better)
Current ratio3.19 (better)2.31
Altman Z-score1.422.13 (better)
Piotroski F-score7 (better)5
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions46.3%111%
Held by insiders9.2%18.1%
Insider net buying, 12 months$361K (better)$101K
Short interest, % of float7.0%22.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.